Connection
Lisa Bero to Off-Label Use
This is a "connection" page, showing publications Lisa Bero has written about Off-Label Use.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.700 |
|
|
|
-
Formoso G, Marata AM, Magrini N, Bero L. A clearer view of evidence in treating macular degeneration: off-label policies and independent research. Cochrane Database Syst Rev. 2014 Sep 15; (9):ED000090.
Score: 0.487
-
Chiu Y, Bero L, Hessol NA, Lexchin J, Harrington C. A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents. Health Policy. 2015 Jun; 119(6):802-13.
Score: 0.126
-
Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med. 2009 Nov 12; 361(20):1963-71.
Score: 0.087